Madison Avenue Partners’s Globus Medical GMED Stock Holding History

Madison Avenue Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.8M	Sell	717,476 -1,907,275	-73%	-$171M	2.69%	13
2025 Q4	$229M	Buy	2,624,751 +76,588	+3%	+$5.81M	9.85%	3
2025 Q3	$146M	Buy	2,548,163 +836,015	+49%	+$48.1M	8.71%	5
2025 Q2	$101M	Buy	+1,712,148	New	+$111M	6.75%	7
2024 Q4	–	Sell	-1,137,050	Closed	-$81.3M	–	18
2024 Q3	$81.3M	Sell	1,137,050 -279,118	-20%	-$19.7M	7.54%	5
2024 Q2	$97M	Buy	1,416,168 +712,892	+101%	+$42.6M	12.25%	3
2024 Q1	$37.7M	Buy	+703,276	New	+$37.8M	6.09%	7

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Madison Avenue Partners's GMED Position: Q1 2026 in Review

Madison Avenue Partners reduced its Globus Medical (GMED) stake by 73% in Q1 2026, selling an estimated $171M and leaving 717,476 shares worth $61.8M. The position accounts for 2.69% of the portfolio, ranked #13.

Madison Avenue Partners first reported a position in GMED in Q1 2024 and has held it in 7 quarters since. The position peaked at $229M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Madison Avenue Partners held 717,476 shares of Globus Medical worth $61.8M as of Q1 2026.
Madison Avenue Partners sold 1,907,275 Globus Medical shares in Q1 2026, an estimated $171M.
Globus Medical made up 2.69% of Madison Avenue Partners's portfolio in Q1 2026, its #13 holding.
Madison Avenue Partners first reported a position in Globus Medical in Q1 2024 and has held it in 7 quarters since.
Madison Avenue Partners's Globus Medical position peaked at $229M in Q4 2025.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Madison Avenue Partners's 13F filing for Q1 2026, filed 15 May 2026.